📰 Takeover Act News
Page 2 - Takeover Act News Today
Fast, Ad-Free News Updates
Stay updated with breaking news from Takeover Act. Real-time updates on events, politics, business and more.
April 11, 2024
EQS-News: MorphoSys AG / Key word(s): Mergers & Acquisitions/Disposal MorphoSys’ Management Board and Supervisory ...
April 11, 2024
MorphoSys Management Board and Supervisory Board Recommend Shareholders ...
March 13, 2024
EQS-News: MorphoSys AG / Key word: Annual Report MorphoSys AG Reports Fourth Quarter and Full Year 2023 Financial Results and Provides Corporate Update 13.03.2024 / 21:01...
February 28, 2024
EQSAdhoc Kontron AG Key word Mergers & Acquisitions Adhoc Kontron AG LinzAustria Closing conditions met for the acquisition of around 59% of the shares in KATEK SE 28Feb2024 1200 CETCEST Disclosu
February 28, 2024
Adhoc: Kontron AG, Linz/Austria, Closing conditions met for the acquisition of around 59% of the shares in KATEK SE
February 28, 2024
EQS-Ad-hoc: Kontron AG / Key word: Mergers & Acquisitions Adhoc: Kontron AG, Linz/Austria, Closing conditions met for the acquisition of around 59% of the shares in KATEK SE 28-Feb-2024 /...
February 28, 2024
EQS-Ad-hoc: Kontron AG / Key word(s): Mergers & Acquisitions Adhoc: Kontron AG, Linz/Austria, Closing conditions met for the acquisit...
February 28, 2024
EQS-News: Südzucker AG / Key word(s): Tender Offer Südzucker AG successfully completes delisting tender offer ...
February 6, 2024
Tafasitamab sold to IncyteNovartis to launch a voluntary public takeover offer for all MorphoSys shares at a price of € 68.00 per share in cashShareholders benefit from attractive premium of 94 percent to the one-month volume weighted average price before January 25, 2024Novartis provides ample resources to maximize...
February 6, 2024
Germany - MorphoSys AG today announced the company entered into a Business Combination Agreement with Novartis data42 AG and Novartis AG based on Novartis intention to submit a voluntary public...